BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32653653)

  • 1. Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study.
    Leurs A; Dubucquoi S; Machuron F; Balden M; Renaud F; Rogeau S; Lopez B; Lambert M; Morell-Dubois S; Maillard H; Béhal H; Hachulla E; Launay D; Sobanski V
    Joint Bone Spine; 2021 Jan; 88(1):105048. PubMed ID: 32653653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study.
    Montagnese F; Babačić H; Eichhorn P; Schoser B
    J Neurol; 2019 Jun; 266(6):1358-1366. PubMed ID: 30840145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
    Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
    Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients.
    Platteel ACM; Wevers BA; Lim J; Bakker JA; Bontkes HJ; Curvers J; Damoiseaux J; Heron M; de Kort G; Limper M; van Lochem EG; Mulder AHL; Saris CGJ; van der Valk H; van der Kooi AJ; van Leeuwen EMM; Veltkamp M; Schreurs MWJ; Meek B; Hamann D
    J Transl Autoimmun; 2019 Dec; 2():100013. PubMed ID: 32743501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
    Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
    Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
    Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
    Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective study.
    Lackner A; Tiefenthaler V; Mirzayeva J; Posch F; Rossmann C; Kastrati K; Radner H; Demel U; Gretler J; Stotz M; Graninger WB; Stradner MH
    Ther Adv Musculoskelet Dis; 2020; 12():1759720X20975907. PubMed ID: 33343724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myositis-associated antibodies predict the severity of lung involvement in adult patients with inflammatory myositis - a cohort study of 70 adult patients with myositis in a single center.
    Marklund J; Hanna B; Jin T; Pullerits R
    Front Med (Lausanne); 2024; 11():1340310. PubMed ID: 38606156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients.
    Negalur NV; Ekbote GG; Raval DN; Tanna DV; Kazi WS; Bindroo MA; Yadavalli DJ; Gupta R
    Ann Indian Acad Neurol; 2021; 24(4):552-558. PubMed ID: 34728950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
    Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
    Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation study on anti-Ro52 antibodies frequently co-occur with other myositis-specific and myositis-associated autoantibodies].
    Zheng YM; Hao HJ; Liu YL; Guo J; Zhao YW; Zhang W; Yuan Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1088-1092. PubMed ID: 33331318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies.
    Maundrell A; Proudman S; Limaye V
    Rheumatol Int; 2019 Oct; 39(10):1777-1781. PubMed ID: 31385080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myositis-Specific Antibodies and Myositis-Associated Antibodies in Patients With Idiopathic Inflammatory Myopathies From the PANLAR Myositis Study Group.
    González-Bello Y; Garcia-Valladares I; Reyes-Pérez IV; García-Cerda D; Medrano-Ramírez G; Navarro-Zarza JE; Andrade-Ortega L; Maradiaga-Ceceña M; Cardenas-Anaya A; Nava-Zavala AH; Orozco-Barocio G; Vázquez-Del Mercado M; Rojo-Mejia A; Loyo E; Gottschalk P; Iglesias-Gamarra A; Vega K; Rojas C; Mantilla R; Gómez G; García-Kutzbach A; Fritzler MJ; García-De La Torre I
    J Clin Rheumatol; 2021 Dec; 27(8):e302-e306. PubMed ID: 32084069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Clinical Correlates of Myositis Specific Autoantibodies in Idiopathic Immune-Mediated Inflammatory Myositis - Results from a Multicentric Cohort (MyoIN) from India.
    Rajasekhar L; Shobha V; Narasimhan A; Bhat V; Amin SN; Misra R
    J Assoc Physicians India; 2021 Jan; 69(1):36-40. PubMed ID: 34227774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
    Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A
    Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.
    Cavazzana I; Richards M; Bentow C; Seaman A; Fredi M; Giudizi MG; Palterer B; Pratesi F; Migliorini P; Franceschini F; Satoh M; Ceribelli A; Mahler M
    J Immunol Methods; 2019 Nov; 474():112661. PubMed ID: 31442464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
    Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
    J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.